However, blockade of ICAM-1 with the decrease in cell-cell adhesion promoted IgG production from moderate-to-severe SLE patients, which could be mirrored with the results from 72 h-stimulated CD4+ T cells from healthy donors. Here, ICAM1 is linked to systemic lupus erythematosus.